tiprankstipranks

Mark Pruzanski Insider Profile

4 Followers
Mark Pruzanski, Director at Intercept Pharma, holds 618.89K shares in Intercept Pharma (Ticker: ICPT), holds ― shares in Equillium (Ticker: EQ).
tipranks
Mark Pruzanski

Mark Pruzanski
Intercept Pharma (ICPT)
Director

Ranked #10,878 out of 97,825 Corporate Insiders

Profitable Transactions

69%
9 out of 13 Profitable Transactions

Average Return

+12.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Mark Pruzanski does not currently own shares as a corporate insider.
A breakdown of Mark Pruzanski's holdings

Insider Roles

Equillium
(EQ)
Director
Roles that Mark Pruzanski holds in companies

Most Profitable Insider Trade

Stock:
Intercept Pharma
(ICPT)
Rating:Informative Buy
Date:Apr 09, 2018 - Apr 09, 2019
Return:+70.90%
The most profitable trade made by Mark Pruzanski

Mark Pruzanski's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ICPT
Intercept Pharma
Dec 02, 2021
Uninformative Buy
105.63K
$11.76M
Equillium
Director
List of latest transactions for each holding click on a transaction to see Mark Pruzanski's performance on stock

Mark Pruzanski insider profile FAQ

What is the percentage of profitable transactions made by Mark Pruzanski?
The percentage of profitable transactions made by Mark Pruzanski is 69%.
    What is the average return per transaction made by Mark Pruzanski?
    The average return per transaction made by Mark Pruzanski is 12.20%.
      What stocks does Mark Pruzanski hold?
      Mark Pruzanski holds: ICPT, EQ stocks.
        What was Mark Pruzanski’s latest transaction?
        Mark Pruzanski latest transaction was an Uninformative Buy of $105.63K.
          What was Mark Pruzanski's most profitable transaction?
          Mark Pruzanski’s most profitable transaction was an Informative Buy of ICPT stock on April 9, 2018. The return on the trade was 70.90%.
            What is Mark Pruzanski's role in Intercept Pharma?
            Mark Pruzanski's role in Intercept Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.